These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 15619403)
1. Comparison of quantitative angiographic parameters with the magnitude of neointimal hyperplasia measured by volumetric intravascular ultrasound in patients treated with bare metal and nonpolymeric paclitaxel-coated stents. Mintz GS; Hong MK; Raizner AE; Lee CW; Kim JJ; Escolar E; Fearnot NE; Park SW; Park SJ; Weissman NJ Am J Cardiol; 2005 Jan; 95(1):105-7. PubMed ID: 15619403 [TBL] [Abstract][Full Text] [Related]
2. Intravascular ultrasound assessment of neointima distribution and the length of stent that was free of intravascular ultrasound-detectable intimal hyperplasia in paclitaxel-eluting stents. Mintz GS; Hong MK; Raizner AE; Lee CW; Kim JJ; Escolar E; Fearnot NE; Park SW; Park SJ; Weissman NJ Am J Cardiol; 2005 Jan; 95(1):107-9. PubMed ID: 15619404 [TBL] [Abstract][Full Text] [Related]
3. Comparison of zotarolimus-eluting stents with sirolimus-eluting and paclitaxel-eluting stents: intimal hyperplasia and vascular changes assessed by volumetric intravascular ultrasound analysis. Kang SJ; Mintz GS; Park DW; Lee SW; Kim YH; Lee CW; Han KH; Kim JJ; Park SW; Park SJ Circ Cardiovasc Interv; 2011 Apr; 4(2):139-45. PubMed ID: 21364151 [TBL] [Abstract][Full Text] [Related]
4. Two-year follow-up of the quantitative angiographic and volumetric intravascular ultrasound analysis after nonpolymeric paclitaxel-eluting stent implantation: late "catch-up" phenomenon from ASPECT Study. Park DW; Hong MK; Mintz GS; Lee CW; Song JM; Han KH; Kang DH; Cheong SS; Song JK; Kim JJ; Weissman NJ; Park SW; Park SJ J Am Coll Cardiol; 2006 Dec; 48(12):2432-9. PubMed ID: 17174179 [TBL] [Abstract][Full Text] [Related]
5. Small stent size and intimal hyperplasia contribute to restenosis: a volumetric intravascular ultrasound analysis. Dussaillant GR; Mintz GS; Pichard AD; Kent KM; Satler LF; Popma JJ; Wong SC; Leon MB J Am Coll Cardiol; 1995 Sep; 26(3):720-4. PubMed ID: 7642865 [TBL] [Abstract][Full Text] [Related]
6. A paclitaxel-eluting stent for the prevention of coronary restenosis. Park SJ; Shim WH; Ho DS; Raizner AE; Park SW; Hong MK; Lee CW; Choi D; Jang Y; Lam R; Weissman NJ; Mintz GS N Engl J Med; 2003 Apr; 348(16):1537-45. PubMed ID: 12700373 [TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of the effects of paclitaxel-eluting stents versus bare metal stents on volumetric intravascular ultrasound in patients with versus without diabetes mellitus. Kimura M; Mintz GS; Weissman NJ; Dawkins KD; Grube E; Ellis SG; Cannon LA; Masud Z; Mandinov L; Baim D; Stone GW Am J Cardiol; 2008 May; 101(9):1263-8. PubMed ID: 18435955 [TBL] [Abstract][Full Text] [Related]
8. The effect of variable dose and release kinetics on neointimal hyperplasia using a novel paclitaxel-eluting stent platform: the Paclitaxel In-Stent Controlled Elution Study (PISCES). Serruys PW; Sianos G; Abizaid A; Aoki J; den Heijer P; Bonnier H; Smits P; McClean D; Verheye S; Belardi J; Condado J; Pieper M; Gambone L; Bressers M; Symons J; Sousa E; Litvack F J Am Coll Cardiol; 2005 Jul; 46(2):253-60. PubMed ID: 16022951 [TBL] [Abstract][Full Text] [Related]
9. Impact of preinterventional arterial remodeling on neointimal hyperplasia after implantation of (non-polymer-encapsulated) paclitaxel-coated stents: a serial volumetric intravascular ultrasound analysis from the ASian Paclitaxel-Eluting Stent Clinical Trial (ASPECT). Mintz GS; Tinana A; Hong MK; Lee CW; Kim JJ; Fearnot NE; Park SW; Park SJ; Weissman NJ Circulation; 2003 Sep; 108(11):1295-8. PubMed ID: 12952833 [TBL] [Abstract][Full Text] [Related]
10. Long-term vascular changes after drug-eluting stent implantation assessed by serial volumetric intravascular ultrasound analysis. Kang SJ; Park DW; Mintz GS; Lee SW; Kim YH; Lee CW; Han KH; Kim JJ; Park SW; Park SJ Am J Cardiol; 2010 May; 105(10):1402-8. PubMed ID: 20451685 [TBL] [Abstract][Full Text] [Related]
11. Revisiting late loss and neointimal volumetric measurements in a drug-eluting stent trial: analysis from the SPIRIT FIRST trial. Tsuchida K; García-García HM; Ong AT; Valgimigli M; Aoki J; Rademaker TA; Morel MA; van Es GA; Bruining N; Serruys PW Catheter Cardiovasc Interv; 2006 Feb; 67(2):188-97. PubMed ID: 16400664 [TBL] [Abstract][Full Text] [Related]
12. Vascular response to sirolimus-eluting stents delivered with a nonaggressive implantation technique: comparison of intravascular ultrasound results from the multicenter, randomized E-SIRIUS, and SIRIUS trials. Hoffmann R; Guagliumi G; Musumeci G; Reimers B; Petronio AS; Disco C; Amoroso G; Moses JW; Fitzgerald PJ; Schofer J; Leon MB; Breithardt G Catheter Cardiovasc Interv; 2005 Dec; 66(4):499-506. PubMed ID: 16273564 [TBL] [Abstract][Full Text] [Related]
13. Paclitaxel coating reduces in-stent intimal hyperplasia in human coronary arteries: a serial volumetric intravascular ultrasound analysis from the Asian Paclitaxel-Eluting Stent Clinical Trial (ASPECT). Hong MK; Mintz GS; Lee CW; Song JM; Han KH; Kang DH; Song JK; Kim JJ; Weissman NJ; Fearnot NE; Park SW; Park SJ; Circulation; 2003 Feb; 107(4):517-20. PubMed ID: 12566359 [TBL] [Abstract][Full Text] [Related]
14. Polymer-based paclitaxel-eluting stents reduce in-stent neointimal tissue proliferation: a serial volumetric intravascular ultrasound analysis from the TAXUS-IV trial. Weissman NJ; Koglin J; Cox DA; Hermiller J; O'Shaughnessy C; Mann JT; Turco M; Caputo R; Bergin P; Greenberg J; Kutcher M; Wong SC; Strickland W; Mooney M; Russell ME; Ellis SG; Stone GW J Am Coll Cardiol; 2005 Apr; 45(8):1201-5. PubMed ID: 15837249 [TBL] [Abstract][Full Text] [Related]
15. Intravascular ultrasonic comparative analysis of degree of intimal hyperplasia produced by four different stents in the coronary arteries. Hoffmann R; Radke PW; Ortlepp JR; Haager PK; Blindt R; Iofina E; Franke A; Langenberg R; Weber C; Hanrath P Am J Cardiol; 2004 Dec; 94(12):1548-50. PubMed ID: 15589014 [TBL] [Abstract][Full Text] [Related]
16. Neointimal hyperplasia after sirolimus-eluting and paclitaxel-eluting stent implantation in diabetic patients: the Randomized Diabetes and Drug-Eluting Stent (DiabeDES) Intravascular Ultrasound Trial. Jensen LO; Maeng M; Thayssen P; Christiansen EH; Hansen KN; Galloe A; Kelbaek H; Lassen JF; Thuesen L Eur Heart J; 2008 Nov; 29(22):2733-41. PubMed ID: 18832385 [TBL] [Abstract][Full Text] [Related]
17. Effect of the polymer-based, paclitaxel-eluting TAXUS Express stent on vascular tissue responses: a volumetric intravascular ultrasound integrated analysis from the TAXUS IV, V, and VI trials. Weissman NJ; Ellis SG; Grube E; Dawkins KD; Greenberg JD; Mann T; Cannon LA; Cambier PA; Fernandez S; Mintz GS; Mandinov L; Koglin J; Stone GW Eur Heart J; 2007 Jul; 28(13):1574-82. PubMed ID: 17540849 [TBL] [Abstract][Full Text] [Related]
18. Volumetric intravascular ultrasound assessment of neointimal hyperplasia and nonuniform stent strut distribution in sirolimus-eluting stent restenosis. Sano K; Mintz GS; Carlier SG; Fujii K; Takebayashi H; Kimura M; Costa JR; Tanaka K; Costa RA; Lui J; Weisz G; Moussa I; Dangas GD; Mehran R; Lansky AJ; Kreps EM; Collins M; Stone GW; Moses JW; Leon MB Am J Cardiol; 2006 Dec; 98(12):1559-62. PubMed ID: 17145209 [TBL] [Abstract][Full Text] [Related]
19. Relation of intimal hyperplasia thickness to stent size in paclitaxel-coated stents. Escolar E; Mintz GS; Hong MK; Lee CW; Kim JJ; Fearnot NE; Park SW; Park SJ; Weissman NJ Am J Cardiol; 2004 Jul; 94(2):196-8. PubMed ID: 15246900 [TBL] [Abstract][Full Text] [Related]
20. Sirolimus-eluting stent implantation and beta-irradiation for the treatment of in-stent restenotic lesions: comparison of underlying mechanisms of acute gain and late loss as assessed by volumetric intravascular ultrasound. Schiele TM; König A; Rieber J; Erhard I; Leibig M; Theisen K; Siebert U; Klauss V Am Heart J; 2005 Aug; 150(2):351-7. PubMed ID: 16086942 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]